Fox Chase Cancer Center News

PHILADELPHIA (May 20, 2013)—Fox Chase Cancer Center recently honored Margaret Foti, PhD, MD (hc), CEO of the American Association for Cancer Research (AACR), with the 2013 Stanley P. Reimann Honor Award for her significant contributions to cancer science and medicine.

PHILADELPHIA, PA (May 8, 2013)—Fox Chase Cancer Center will be hosting a Cancer Conversations LIVE event featuring author Jessica Wapner on Tuesday, May 14 at 7:00 p.m. in the Fox Chase Auditorium (Center Building, 333 Cottman Aveue, Philadelphia). At the event, Jessica will discuss her new book The Philadelphia Chromosome: a Mutant Gene and the Quest to Cure Cancer at the Genetic Level—just published this spring.

(Philadelphia, PA, April 30, 2013) – Sixty (60) Temple physicians have been named to Philadelphia magazine’s annual “Top Doctors” list. Nominated by their professional peers, the physicians on the list practice at Temple University Hospital, Fox Chase Cancer Center and Jeanes Hospital.

PHILADELPHIA, PA (April 17, 2013)—Join the Eileen Stein Jacoby Fund as they host the 4th Annual FitLife Marathon for a Cure on Sunday, April 21 from 1:00-5:00 p.m. at the FitLife Performance Center in Ivyland, PA (157 Railroad Drive). Every year the event brings together high school and college students from Philadelphia, Montgomery and Bucks County to participate in a variety of fitness activities—running, fitness training, relays, tag and more—to help raise funds for breast cancer research at Fox Chase Cancer Center.

WASHINGTON, DC (April 10, 2013)—A common virus known to cause cervical and head and neck cancers may also trigger some cases of lung cancer, according to new research presented by Fox Chase Cancer Center at the AACR Annual Meeting 2013 on Wednesday, April 10.

Examining tissue samples from lung cancer patients, the researchers found that nearly 6% showed signs they may have been driven by a strain of human papillomavirus (HPV) known to cause cancer.

WASHINGTON, DC (April 9, 2013)—A new chemotherapy regimen appears to produce minimal side effects in patients with lung cancer that has not responded to previous therapy, paving the way for additional research to determine if the new regimen also helps shrink tumors, according findings to be presented by Fox Chase Cancer Center researchers at the AACR Annual Meeting 2013 on Tuesday, April 9.

WASHINGTON, DC (April 9, 2013)—Head and neck cancers typically begin in squamous cells that line moist surfaces inside the mouth, nose and throat. Squamous cell carcinoma of the head and neck (HNSCC) is the sixth most common type of cancer in the United States, and it is sometimes preceded by the appearance of changes inside the oral cavity called precancerous lesions. The most common type of change is a white patch known as a leukoplakia.

WASHINGTON, DC (April 9, 2013)—A variety of mutations may give rise to breast cancer, but scientists generally assume that it starts off with just a few. That’s because later-stage breast cancers tend to have more mutations—they are more heterogeneous—than early stage cancers. Now, new findings by scientists at Fox Chase Cancer Center demonstrate heterogeneity is prevalent even within legions of ductal carcinoma in situ (DCIS), the most common, earliest stage non-invasive breast cancer (stage 0).